June 2, 2020 / 11:07 AM / a month ago

BRIEF-Bristol Myers Announces Results From Phase 3 Zeposia Study In Ulcerative Colitis

June 2 (Reuters) - BRISTOL MYERS:

* BRISTOL MYERS - ANNOUNCES TOPLINE RESULTS FROM PHASE 3 TRUE NORTH TRIAL EVALUATING ZEPOSIA IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

* BRISTOL MYERS - PHASE 3 TRUE NORTH ZEPOSIA TRIAL ALSO MET KEY SECONDARY ENDPOINTS OF CLINICAL RESPONSE AND ENDOSCOPIC IMPROVEMENT

* BRISTOL MYERS - PHASE 3 TRUE NORTH ZEPOSIA TRIAL MET PRIMARY ENDPOINTS OF CLINICAL REMISSION IN INDUCTION AT WEEK 10, IN MAINTENANCE AT WEEK 52

* BRISTOL MYERS - SAFETY PROFILE OF ZEPOSIA IN PHASE 3 TRUE NORTH TRIAL WAS CONSISTENT WITH PREVIOUSLY REPORTED TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below